Chlamydial protease-like activity factor—insights into immunity and vaccine development

This publication has 34 references indexed in Scilit:

• Actin and Intermediate Filaments Stabilize the Chlamydia trachomatis Vacuole by Forming Dynamic Structural Scaffolds
  Cell Host & Microbe, 2008
• Induction of Cross-Serovar Protection against Genital Chlamydial Infection by a Targeted Multisubunit Vaccination Approach
  Clinical and Vaccine Immunology, 2007
• Expression, Processing, and Localization of PmpD of Chlamydia trachomatis Serovar L2 during the Chlamydial Developmental Cycle
  PLOS ONE, 2007
• Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection
  Vaccine, 2007
• Intranasal Vaccination with a Secreted Chlamydial Protein Enhances Resolution of GenitalChlamydia muridarumInfection, Protects against Oviduct Pathology, and Is Highly Dependent upon Endogenous Gamma Interferon Production
  Infection and Immunity, 2007
• Chlamydial Protease-Like Activity Factor Induces Protective Immunity against Genital Chlamydial Infection in Transgenic Mice That Express the Human HLA-DR4 Allele
  Infection and Immunity, 2006
• The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells
  Cellular Immunology, 2006
• Inhibition of Proteolytic Activity of a Chlamydial Proteasome/Protease-Like Activity Factor by Antibodies from Humans Infected with Chlamydia trachomatis
  Infection and Immunity, 2005
• Human Antibody Responses to a Chlamydia-Secreted Protease Factor
  Infection and Immunity, 2004
• Degradation of Transcription Factor Rfx5 during the Inhibition of Both Constitutive and Interferon γ–Inducible Major Histocompatibility Complex Class I Expression in Chlamydia-Infected Cells
  The Journal of Experimental Medicine, 2000